Nektar Therapeutics NKTR Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.06B.
The official record: Nektar Therapeutics’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Nektar Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Nektar Therapeutics's market capitalization?
- Nektar Therapeutics (NKTR) reported market capitalization of $2.06B in Q1 2026.
- How has Nektar Therapeutics's market capitalization changed year-over-year?
- Nektar Therapeutics's market capitalization increased by 1531.0% year-over-year, from $126.55M to $2.06B.
- What is the long-term trend for Nektar Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Nektar Therapeutics's market capitalization has grown at a -22.8% compound annual growth rate (CAGR), from $3.14B to $860.04M.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.